Professor | Xiangjun Zhou | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Xiangjun Zhou

Contact Information

24816439@qq.com

Language ability

English, Chinese

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	2004.09-2009.06 Bachelor of Clinical Medicine, Hubei College of Medicine 2009.09-2012.06 Master of Surgery, Wuhan University 2012.09-2015.06 PhD in Surgery, Wuhan University Received two National Natural Science Foundation projects
Work Experience	2015.07-2020.12 Attending Physician, Urology Department, Renmin Hospital, Wuhan University 2015.09-2017.04 Visiting Scholar, Medical College of Georgia, USA 2020.12-present Associate Chief Physician, Urology Department, Renmin Hospital, Wuhan University
Awards	2022 Hubei Province Science and Technology Progress First Prize: Key Techniques and Clinical Application of Minimally Invasive Treatment for Kidney Stones

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

Work Experience

2015.07-2020.12 Attending Physician, Urology Department, Renmin Hospital, Wuhan University
2015.09-2017.04 Visiting Scholar, Medical College of Georgia, USA
2020.12-present Associate Chief Physician, Urology Department, Renmin Hospital, Wuhan University

Awards

2022 Hubei Province Science and Technology Progress First Prize: Key Techniques and Clinical Application of Minimally Invasive Treatment for Kidney Stones

Areas of Focus	Kidney stone disease prevention and treatment Acute kidney injury and fibrosis
Publications	Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys, Zhao S, Cheng F, Zhou XJ, et al., 2021 Tubular cell-derived exosomal miR-150-5p contributes to renal fibrosis following unilateral ischemia-reperfusion injury by activating fibroblast in vitro and in vivo, Zhou XJ, Zhao S, Li W, Cheng F, et al., 2021 Novel lncRNA XLOC_032768 protects against renal tubular epithelial cells apoptosis in renal ischemia–reperfusion injury by regulating FNDC3B/TGF-β1, Zhou XJ, Li YW, Wu C, Cheng F, 2020 Histone H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced AKI, Li BJ, Xia YQ, Mei SQ, Zhou XJ, Cheng F, 2023 p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis, Ye ZH, Xia YQ, Li L, Zhou XJ, Fan Cheng F, 2023

Areas of Focus

Kidney stone disease prevention and treatment
Acute kidney injury and fibrosis

Publications

Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys, Zhao S, Cheng F, Zhou XJ, et al., 2021
Tubular cell-derived exosomal miR-150-5p contributes to renal fibrosis following unilateral ischemia-reperfusion injury by activating fibroblast in vitro and in vivo, Zhou XJ, Zhao S, Li W, Cheng F, et al., 2021
Novel lncRNA XLOC_032768 protects against renal tubular epithelial cells apoptosis in renal ischemia–reperfusion injury by regulating FNDC3B/TGF-β1, Zhou XJ, Li YW, Wu C, Cheng F, 2020
Histone H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced AKI, Li BJ, Xia YQ, Mei SQ, Zhou XJ, Cheng F, 2023
p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis, Ye ZH, Xia YQ, Li L, Zhou XJ, Fan Cheng F, 2023

Kidney Stones Prevention Treatment Urology Renal Fibrosis Acute Kidney Injury Fibrosis Pathophysiology Clinical Research Therapeutics

Jia Guo - Wuhan University

Zhang Aihua - Nanjing University

Liu Tongzu - Wuhan University

View All

Personal Information